Cargando…
Early introduction oral immunotherapy for IgE‐mediated cow's milk allergy: A follow‐up study confirms this approach as safe and appealing to parents
INTRODUCTION: Early introduction oral immunotherapy (E‐OIT) in the first year of life can be a safe treatment for infants with cow's milk allergy (CMA). Once the protocol is completed, doubts remain whether children achieve tolerance or remain desensitized. According to current guidelines, this...
Autores principales: | Badina, Laura, Levantino, Laura, Carrato, Valentina, Peruch, Giulia, Celsi, Fulvio, Barbi, Egidio, Berti, Irene, Longo, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342213/ https://www.ncbi.nlm.nih.gov/pubmed/34002933 http://dx.doi.org/10.1002/iid3.447 |
Ejemplares similares
-
Life‐threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure
por: Badina, Laura, et al.
Publicado: (2022) -
Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy
por: Benelli, Elisa, et al.
Publicado: (2022) -
Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy
por: Badina, Laura, et al.
Publicado: (2021) -
Cow's Milk Allergy: the Relevance of IgE
por: Tosca, Maria Angela, et al.
Publicado: (2016) -
Markers of gut mucosal inflammation and cow’s milk specific immunoglobulins in non-IgE cow’s milk allergy
por: Merras-Salmio, Laura, et al.
Publicado: (2014)